Author:
O’Callaghan J.,Barry S. P.,Bermingham M.,Morris J. M.,Griffin B. T.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference94 articles.
1. Cornes P (2012) The economic pressures for biosimilar drug use in cancer medicine. Target Oncol 7(Suppl 1):S57–S67
2. McCamish M, Woollett G (2011) Worldwide experience with biosimilar development. MAbs 3(2):209–217
3. IMS Health (2017) The impact of biosimilar competition in Europe. Available from:
http://ec.europa.eu/DocsRoom/documents/23102
. 5 Aug 2018
4. Food and Drug Administration (FDA) (2015) FDA approves first biosimilar product Zarxio. Available from:
https://wayback.archive-it.org/7993/20170111224313/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm436648.htm
. 5 Aug 2018
5. Walsh G, Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotech 24(10):1241–1252
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献